The World Health Organisation has warned that 73 countries are running low on antiretroviral medicines (ARVs), and attributed the shortages to Covid-19 disruptions.
Indeed, disruptions wrought by the coronavirus pandemic are gargantuan, but do not provide a basis for abandoning other equally important projects, like providing antiretroviral drugs to HIV patients.